Search research articles
Contact Us
Filters
Showing results (31-40 of 93) with videos related to
Page
of 10
Sort By:
European Journal of Medicinal Chemistry
|
February 14, 2002
Conformationally restrained analogues of sympathomimetic catecholamines. Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2',5'-morpholines]
Aldo Balsamo, Annalina Lapucci, Clementina Manera, et al.
International Journal of Molecular Sciences
|
July 6, 2018
Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells
Antonella Capozzi, Vincenzo Mattei, Stefano Martellucci, et al.
Frontiers in Oncology
|
March 13, 2023
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
Andrea Caddeo, Marina Serra, Francesca Sedda, et al.
Bioorganic & Medicinal Chemistry
|
November 8, 2003
Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonists
Giuseppe Saccomanni, Muwaffag Badawneh, Barbara Adinolfi, et al.
Journal of Analytical Toxicology
|
December 2, 2006
Use of capillary electrophoresis and poly(ethylene oxide) as the coating agent for the determination of substances related to heroin addiction and treatment
Niccoló Di Pietro, Giorgio Placanica, Italbo Fiorini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 12, 2015
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors
Carlotta Granchi, Flavio Rizzolio, Vittorio Bordoni, et al.
Molecules (Basel, Switzerland)
|
May 12, 2019
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma
Silvia Tampucci, Sara Carpi, Maria Digiacomo, et al.
Life (Basel, Switzerland)
|
December 11, 2020
Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
Beatrice Polini, Chiara Cervetto, Sara Carpi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
July 1, 2018
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer
Beatrice Polini, Maria Digiacomo, Sara Carpi, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
January 24, 2012
A new 4-phenyl-1,8-naphthyridine derivative affects carcinoma cell proliferation by impairing cell cycle progression and inducing apoptosis
Antonella Capozzi, Elisabetta Mantuano, Paola Matarrese, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 93) with videos related to
Sort By:
Page
of 10
European Journal of Medicinal Chemistry
|
February 14, 2002
Conformationally restrained analogues of sympathomimetic catecholamines. Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2',5'-morpholines]
Aldo Balsamo, Annalina Lapucci, Clementina Manera, et al.
International Journal of Molecular Sciences
|
July 6, 2018
Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells
Antonella Capozzi, Vincenzo Mattei, Stefano Martellucci, et al.
Frontiers in Oncology
|
March 13, 2023
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
Andrea Caddeo, Marina Serra, Francesca Sedda, et al.
Bioorganic & Medicinal Chemistry
|
November 8, 2003
Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonists
Giuseppe Saccomanni, Muwaffag Badawneh, Barbara Adinolfi, et al.
Journal of Analytical Toxicology
|
December 2, 2006
Use of capillary electrophoresis and poly(ethylene oxide) as the coating agent for the determination of substances related to heroin addiction and treatment
Niccoló Di Pietro, Giorgio Placanica, Italbo Fiorini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 12, 2015
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors
Carlotta Granchi, Flavio Rizzolio, Vittorio Bordoni, et al.
Molecules (Basel, Switzerland)
|
May 12, 2019
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma
Silvia Tampucci, Sara Carpi, Maria Digiacomo, et al.
Life (Basel, Switzerland)
|
December 11, 2020
Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
Beatrice Polini, Chiara Cervetto, Sara Carpi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
July 1, 2018
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer
Beatrice Polini, Maria Digiacomo, Sara Carpi, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
January 24, 2012
A new 4-phenyl-1,8-naphthyridine derivative affects carcinoma cell proliferation by impairing cell cycle progression and inducing apoptosis
Antonella Capozzi, Elisabetta Mantuano, Paola Matarrese, et al.
Page
of 10